期刊文献+

视网膜母细胞瘤抗原致敏的树突状细胞疫苗抗SO-RB_(50)细胞系的实验研究 被引量:7

An experiment study of in vitro induced antitumor immune responses by vaccination of tumor lysate-pulsed dendritic cells to kill SO-RB_(50)
原文传递
导出
摘要 目的 研究视网膜母细胞瘤 (RB)抗原致敏的树突状细胞 (DC)疫苗体外特异性对RB细胞系SO RB50 杀伤作用 ,为进一步研究RB的治疗提供新的思路。方法 以RB细胞的蛋白抗原体外冲击致敏健康人 (正常对照组 )及RB患者 (患者组 )来源的成熟DC ,并将其与自体T细胞混合培养 ,诱导出抗SO RB50 的特异性细胞毒性T淋巴细胞 (CTL) ,以Burkitt淋巴瘤Raji细胞作为对照靶细胞 ,采用噻唑蓝 (MTT)分别比较CTL对SO RB50 和Raji细胞的杀伤率及正常对照组与RB患者组来源特异性杀伤率的组间差异性。结果 对SO RB50 与Raji 2种靶细胞 ,正常对照组和RB患者组的CTL细胞毒作用均随着效靶比的增加而增加 ,对SO RB50 细胞的杀伤作用各效靶比均强于相应效靶比的Raji细胞(P <0 .0 1) ;各效靶比正常对照组CTL对SO RB50 细胞的特异性杀伤作用均显著强于RB患者组CTL(P <0 .0 1) ;而各效靶比正常对照组与RB患者组CTL对Raji细胞的非特异性杀伤作用则相近 ,两者比较 ,差异无显著意义 (P >0 .0 5 )。结论 应用RB抗原负载DC可诱导出针对SO RB50 细胞抗原特异性的CTL ,这种方法对RB的治疗可能具有潜在的临床应用价值。 Objective To investigate induced antitumor immune responses by vaccination of tumor lysate-pulsed dendritic cells (DC) to kill retinoblastoma cells SO-RB_ 50 . We hope to offer new approach for the treatment of patients with retinoblastoma. Methods DC was pulsed with RB tumor lysates in vitro and incubated with autologous lymphocytes to induce antigen specific CTL (cytotoxic T lymphocyte,CTL). SO-RB_ 50 cells were used as target cells and Raji cells were used as control target cells. Cytotoxicity of CTL was evaluated by MTT method (methyl thiazolyl letrazolium). The specific cytotoxicity of CTL to SO-RB_ 50 and Raji cells was compared. The cytotoxicity of CTL from RB and normal subjects was compared between these two groups. Results Antigen specific CTL showed greater cytotoxicity to SO-RB_ 50 than Raji cells,the difference was statistically significant, P <0.01. The cytotoxicity was dose-dependent to the ratio of CTL/target cell. The nonspecific cytotoxicity to Raji cells was the same in CTL from RB patients and normal subjects,P >0.05. The specific cytotoxicity of CTL from RB patients to SO-RB_ 50 was weaker than that from the healthy subjects,P <0.01. Conclusion DC pulsed with RB tumor lysate in vitro can induce antigen specific CTL which can kill the SO-RB_ 50 target cells specifically. This method may have potential value of therapy for the RB patients. (Chin J Ophthalmol,2004,40:229-233)
出处 《中华眼科杂志》 CAS CSCD 北大核心 2004年第4期229-233,共5页 Chinese Journal of Ophthalmology
基金 国家自然科学基金资助项目 (3 9870 80 1) 广东省自然科学基金资助项目 (980 11) 广东省科技计划基金资助项目 (2 0 0 3A3 0 2 0 3 0 2 ) "2 11"工程基金资助项目 (980 0 7)
关键词 视网膜母细胞瘤 抗原 树突状细胞 疫苗 SO-RB50细胞系 实验 T淋巴细胞 细胞毒性 Retinoblastoma Dendritic cell T-lymphocyte,cytotoxic Immunotherapy,adoptive
  • 相关文献

参考文献15

  • 1Ian H,Camilo C.Fusion induces tumor rejection.Nature,1997,388:626-627. 被引量:1
  • 2Banchereau J,Steinman RM.Dendritic cells and the control of immunity.Nature,1998,392:245-252. 被引量:1
  • 3Romani N,Gumer S, Brang G,et al.Proliferating dendritic cell progenitors in human blood. J Exp Med, 1994,180:83-93. 被引量:1
  • 4Sang DN,Albert DM.Retinoblastoma: clinical and histopathologic features.Hum Pathol, 1982,13: 133-147. 被引量:1
  • 5Hernando J,Kende AS,Milbank JB,et al.Vaccination with autologous tumor antigen-pulsed dendritic cells in advanced gynaecological maligancies:clinical and immunological evaluation of a phase Ⅰ trial.Cancer Immunol Immunother,2002,51:45-52. 被引量:1
  • 6Steinman RM,Dhodapkar M.Active immunization against cancer with dendritic cells:the near future.Int J Cancer,2001,94:459-473. 被引量:1
  • 7Wulfing C,Davis MM.A receptor/cytoskeletal movement triggered by costimulation during T cell activation.Science,1998,282:2266-2269. 被引量:1
  • 8易玉珍.视网膜肿瘤[A].见:孙为荣 主编.眼科病理学[C].北京:人民卫生出版社,1997.367-429. 被引量:4
  • 9金捷,区宝祥.人视网膜母细胞瘤细胞系SO—Rb50的建立及其生物学特征[J].中华眼科杂志,1990,26(6):355-359. 被引量:13
  • 10唐松,李永平,钟秀风,郑健樑,颜建华,应方微,林征,冯官光.视网膜母细胞瘤患者外周血树突状细胞的体外诱导扩增及鉴定[J].中华眼科杂志,2003,39(2):105-108. 被引量:5

二级参考文献17

共引文献20

同被引文献167

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部